Hôpital Huriez - Service des maladies de l'appareil digestif et de la nutrition
Lille, 59037, France
NCT Number: NCT01698970
A double-blind, multicentre, stratified by centre, randomised, parallel study with two groups of adult patients operated on for Crohn's disease, to determine if oral ingestion of probiotics could prevent the appearance of Crohn's disease recurrent endoscopic ileo-colonic lesions 12 months after surgery. Patients will consume 900 mg/day of active product (N=56) or control product (N=56) during one year.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lille, 59037, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1- 6 test products/day
2- 6 control poducts/day
Danone Global Research & Innovation Center
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03000101
Colitis, Colitis, Ulcerative
Bologna, Italy
View Trial DetailsNCT07697547
Crohn Disease, Crohn's Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01155362
Crohn Disease, Crohn's Disease
Los Angeles, California, United States
View Trial DetailsNCT04002180
Crohn Disease, Crohn's Disease
Tokyo, Japan
View Trial Details